Details
 

January 21, 2023

Interpreting Clinical Data: Highlights from ASH 2022

Presented by: MSHO and University of Michigan

The Dearborn Inn
20301 Oakwood Blvd.
Dearborn, MI 48124

For driving instructions click here

REGISTRATION INFORMATION
If you are a pharmaceutical member interested in registering for this event, please contact Linda Raveau at lraveau@msho.org or 248-385-5464.

Register before January 8
Physicians: $150
Retirees, PAs, NPs, Nurses, Allied Health Professionals: $50
Fellows: Advance Registration Fee $50 (reimbursed at the conference)
Residents, Students: $25

Register after January 8
Physicians: $175.00
Retirees, PAs, NPs, Nurses, Allied Health Professionals: $100
Fellows: $50
Residents, Students: $25

No refunds will be granted after January 8, 2023.

DESCRIPTION
Faculty from Michigan’s comprehensive cancer centers will bring the most significant abstracts presented at ASH’s Annual Meeting to attendees in a concise, yet comprehensive format. This symposium is needed to disseminate current information to practicing hematologists and oncologists and to improve the overall standard of care and knowledge base.

After completing this activity participants will be able to:

1. Apply advances in scientific and translational research to the care of their patients.
2. Utilize emerging therapies to provide optimal treatment to patients.
3. Implement new practices or review existing ones to improve the quality of care delivered.

To view the AGENDA click here.

Click Here to Register Today!

TARGET AUDIENCE
This activity is appropriate for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Medical Students, and Other Healthcare professionals in the field of Hematology/Oncology.

ACCREDITATION AND CREDIT DESIGNATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and Michigan Society of Hematology and Oncology. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PLANNING COMMITTEE

Asra Ahmed, MD
Associate Professor
Department of Internal Medicine
Division of Hematology/Oncology
Co-Director Scientific Trunk
Michigan Medicine

Samuel M. Silver, MD, PhD, MACP, FASCO
Educational Co-Planner
Assistant Dean for Research
Professor
Internal Medicine/Hematology-Oncology
University of Michigan

Mary Kay Makarewicz
Educational Co-Planner
Executive Director
Michigan Society of Hematology & Oncology

If you have any questions regarding this event, please contact Linda Raveau at lraveau@msho.org or 248-385-5464.

Printer-Friendly Version


Add to Calendar aCLuDhaqizCaPxAftmqF167204 01/21/2023 01/21/2023 true America/New York Interpreting Clinical Data: Highlights from ASH 2022 The Dearborn Inn20301 Oakwood Blvd.Dearborn, MI 48124For driving instructions click hereREGISTRATION INFORMATIONIf you are a pharmaceutical member interested in registering for this event, please contact Linda Raveau at lraveau@msho.org or 248-385-5464.Register before January 8Physicians: $150Retirees, PAs, NPs, Nurses, Allied Health Professionals: $50Fellows: Advance Registration Fee $50 (reimbursed at the conference)Residents, Students: $25Register after January 8Physicians: $175.00Retirees, PAs, NPs, Nurses, Allied Health Professionals: $100Fellows: $50Residents, Students: $25No refunds will be granted after January 8, 2023. DESCRIPTIONFaculty from Michigan’s comprehensive cancer centers will bring the most significant abstracts presented at ASH’s Annual Meeting to attendees in a concise, yet comprehensive format. This symposium is needed to disseminate current information to practicing hematologists and oncologists and to improve the overall standard of care and knowledge base. After completing this activity participants will be able to: 1. Apply advances in scientific and translational research to the care of their patients.2. Utilize emerging therapies to provide optimal treatment to patients.3. Implement new practices or review existing ones to improve the quality of care delivered. To view the AGENDA click here. Click Here to Register Today!TARGET AUDIENCEThis activity is appropriate for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Medical Students, and Other Healthcare professionals in the field of Hematology/Oncology.ACCREDITATION AND CREDIT DESIGNATIONThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and Michigan Society of Hematology and Oncology. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Michigan Medical School designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLANNING COMMITTEEAsra Ahmed, MDAssociate ProfessorDepartment of Internal MedicineDivision of Hematology/OncologyCo-Director Scientific TrunkMichigan MedicineSamuel M. Silver, MD, PhD, MACP, FASCOEducational Co-PlannerAssistant Dean for ResearchProfessorInternal Medicine/Hematology-OncologyUniversity of MichiganMary Kay MakarewiczEducational Co-PlannerExecutive DirectorMichigan Society of Hematology & Oncology If you have any questions regarding this event, please contact Linda Raveau at lraveau@msho.org or 248-385-5464. ----